Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level
Background: High risk blood transfusions can cause a lot of financial and psychological burden to the community. The prevalence of Hepatitis B is useful for evaluating the blood products' safety and donor selection methods. We aimed to predict the prevalence of hepatitis B in Iranian blood don...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2021-09-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/20587 |
id |
doaj-779ff6b7e7e04f2e9a756dc0770c83b0 |
---|---|
record_format |
Article |
spelling |
doaj-779ff6b7e7e04f2e9a756dc0770c83b02021-10-02T18:56:46ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932021-09-0150910.18502/ijph.v50i9.7058Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial LevelNegar Rezaei0Mahtab Maghsodlu1Ali Sheidaei2Sedigheh Amini Kafiabad3Kimiya Gohari4Maryam Zadsar5Farnaz Delavari6Zohreh Sharifi7Moein Yoosefi8Farshad Farzadfar9Mohsen Asadi-Lari101. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, IranBlood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, IranDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IranBlood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, IranDepartment of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranBlood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, IranNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IranBlood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, IranNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran1. Oncopathology Research Centre, Iran University of Medical Sciences, Tehran, Iran 2. Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran Background: High risk blood transfusions can cause a lot of financial and psychological burden to the community. The prevalence of Hepatitis B is useful for evaluating the blood products' safety and donor selection methods. We aimed to predict the prevalence of hepatitis B in Iranian blood donors from 2000-2016. Methods: Positive cases of hepatitis B from 2006 to 2014 were collected from Iranian Blood Transfusion Organization. This database was classified according to the age, provinces, and type of donation. Data was not existed in all subnational levels and all years, therefore, for predicting the hepatitis B prevalence, two separate, Spatio-temporal and mixed model (GLMM) were developed. Results: At the national level, the hepatitis B prevalence declined from 0.69 (0.51 to 0.90) in 2000 to 0.27 (0.21 to 0.33) in 2016. In first-time, regular, and repeated donors, this prevalence declined from 2.31 (1.74 to 2.31), 0.26 (0.19 to 0.34), and 0.51 (0.38 to 0.68) in 2000 to 0.87 (0.69 to 1.09), 0.09 (0.07 to 0.12), and 0.19 (0.14 to 0.24) in 2016. At the provincial level, the highest and lowest prevalence in 2016 was observed in North Khorasan and Gilan. With increasing age, the average prevalence of hepatitis B, increased. Conclusion: Prevalence of hepatitis B in Iranian blood donors has been reduced significantly over 17 years, but still new cases of hepatitis B are reported. By precise monitoring the donor selection process and implementing more sensitive laboratory screening, we can reduce the risk of new infectious agents. https://ijph.tums.ac.ir/index.php/ijph/article/view/20587Hepatitis BPrevalenceBlood donors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Negar Rezaei Mahtab Maghsodlu Ali Sheidaei Sedigheh Amini Kafiabad Kimiya Gohari Maryam Zadsar Farnaz Delavari Zohreh Sharifi Moein Yoosefi Farshad Farzadfar Mohsen Asadi-Lari |
spellingShingle |
Negar Rezaei Mahtab Maghsodlu Ali Sheidaei Sedigheh Amini Kafiabad Kimiya Gohari Maryam Zadsar Farnaz Delavari Zohreh Sharifi Moein Yoosefi Farshad Farzadfar Mohsen Asadi-Lari Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level Iranian Journal of Public Health Hepatitis B Prevalence Blood donors |
author_facet |
Negar Rezaei Mahtab Maghsodlu Ali Sheidaei Sedigheh Amini Kafiabad Kimiya Gohari Maryam Zadsar Farnaz Delavari Zohreh Sharifi Moein Yoosefi Farshad Farzadfar Mohsen Asadi-Lari |
author_sort |
Negar Rezaei |
title |
Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level |
title_short |
Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level |
title_full |
Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level |
title_fullStr |
Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level |
title_full_unstemmed |
Spatio-Temporal Analysis of the Hepatitis B Prevalence in Irani-an Blood Donors from 2000 to 2016 at National and Provincial Level |
title_sort |
spatio-temporal analysis of the hepatitis b prevalence in irani-an blood donors from 2000 to 2016 at national and provincial level |
publisher |
Tehran University of Medical Sciences |
series |
Iranian Journal of Public Health |
issn |
2251-6085 2251-6093 |
publishDate |
2021-09-01 |
description |
Background: High risk blood transfusions can cause a lot of financial and psychological burden to the community. The prevalence of Hepatitis B is useful for evaluating the blood products' safety and donor selection methods. We aimed to predict the prevalence of hepatitis B in Iranian blood donors from 2000-2016.
Methods: Positive cases of hepatitis B from 2006 to 2014 were collected from Iranian Blood Transfusion Organization. This database was classified according to the age, provinces, and type of donation. Data was not existed in all subnational levels and all years, therefore, for predicting the hepatitis B prevalence, two separate, Spatio-temporal and mixed model (GLMM) were developed.
Results: At the national level, the hepatitis B prevalence declined from 0.69 (0.51 to 0.90) in 2000 to 0.27 (0.21 to 0.33) in 2016. In first-time, regular, and repeated donors, this prevalence declined from 2.31 (1.74 to 2.31), 0.26 (0.19 to 0.34), and 0.51 (0.38 to 0.68) in 2000 to 0.87 (0.69 to 1.09), 0.09 (0.07 to 0.12), and 0.19 (0.14 to 0.24) in 2016. At the provincial level, the highest and lowest prevalence in 2016 was observed in North Khorasan and Gilan. With increasing age, the average prevalence of hepatitis B, increased.
Conclusion: Prevalence of hepatitis B in Iranian blood donors has been reduced significantly over 17 years, but still new cases of hepatitis B are reported. By precise monitoring the donor selection process and implementing more sensitive laboratory screening, we can reduce the risk of new infectious agents.
|
topic |
Hepatitis B Prevalence Blood donors |
url |
https://ijph.tums.ac.ir/index.php/ijph/article/view/20587 |
work_keys_str_mv |
AT negarrezaei spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT mahtabmaghsodlu spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT alisheidaei spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT sedighehaminikafiabad spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT kimiyagohari spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT maryamzadsar spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT farnazdelavari spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT zohrehsharifi spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT moeinyoosefi spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT farshadfarzadfar spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel AT mohsenasadilari spatiotemporalanalysisofthehepatitisbprevalenceiniranianblooddonorsfrom2000to2016atnationalandprovinciallevel |
_version_ |
1716848441691209728 |